A systematic review of Lp(a) reporting across Australia has shown significant heterogeneity, with many labs lacking access to on-site testing – something which is likely to contribute to increased testing costs, said researchers.
Educational Partners and Supporters
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.